Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X.

Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Abstract Text:

    po-hsun huangPo-Hsun Huang,yung-hsiang chenYung-Hsiang Chen,yuh-lien chenYuh-Lien Chen,tao-cheng wuTao-Cheng Wu,jaw-wen chenJaw-Wen Chen,shing-jong linShing-Jong Lin,

    BACKGROUND: Endothelial dysfunction and microvascular abnormalities have been reported in patients with cardiac syndrome X (CSX), but the underlying mechanisms are unclear. Recent insights suggest that the injured endothelial monolayer is regenerated by circulating bone marrow-derived endothelial progenitor cells (EPCs). AIM: To test the hypothesis that the biology of altered EPCs might contribute to the pathophysiology of CSX. METHODS: 34 subjects (mean (SD) age: 62 (7) years) were enrolled in the study, including 12 patients with CSX, 12 stable subjects with coronary artery disease (CAD) and 10 healthy controls. The number and adhesive function of EPCs were measured in peripheral-blood samples from these study participants. RESULTS: The baseline characteristics in patients with CSX and CAD were enhanced Framingham risk scores, more hypertension and lower high-density lipoproteins than the controls. Patients with CSX and CAD had significantly decreased endothelium-dependent flow-mediated vasodilation (FMD) compared with normal controls (normal controls vs CSX vs CAD: 10.6% (3.5%) vs 6.1% (1.8%) vs 4.1% (1.9%), p<0.001), but the difference was not found in endothelium-independent nitroglycerine-mediated vasodilation (p = 0.159). Reduced numbers of colony-forming units (CFU) of EPCs were noted in patients with CSX and CAD (normal vs CSX vs CAD: 41 (9) vs 30 (7) vs 14 (7) CFU/well, p<0.001). Levels of EPCs were shown to be associated with FMD (r = 0.557, p = 0.001) and high-density lipoprotein (r = 0.339, p = 0.049). Also, attenuated fibronectin adhesion function of EPCs was found in patients with CSX and CaD compared with normal subjects (104 (12) vs 80 (20) vs 65 (13)/well, p<0.001). CONCLUSIONS: This study clearly showed for the first time that compared with normal subjects, patients with CSX have decreased levels and adhesive function of circulating EPCs. These findings may explain the underlying mechanisms which contribute to the endothelial dysfunction and microvascular abnormalities observed in patients with CSX.

    Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Publishing Authors By Initials

    ph huangPH Huang,yh chenYH Chen,yl chenYL Chen,tc wuTC Wu,jw chenJW Chen,sj linSJ Lin,

    For similar vasodilation research abstracts see: vasodilation research

    PUBMED ID PMID:

    MEDLINE DATE:

    Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Heart (British Cardiac Society)

    VOLUME: 93

    Page Numbers: 1064-70

    Journal Abbreviation: Heart

    ISSN: 1468-201X

    DAY: 8

    MONTH: 05

    YEAR: 2007

    Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9602087

    Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Keywords Mesh Terms:

    KEYWORDS: Vasodilation

    MESH TERMS: pharmacology

    Chemical & Substance for Abstract: Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X. Information

    Substance Name: C-Reactive Protein

    Registry Number: 9007-41-4

    Grant and Affiliation Information for Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X.

    AFFILIATION: Institute of Clinicial Medicine and [corrected] Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan.

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Heart

    REFSOURCE: Heart. 2007 Dec;93(12):1619

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Vascular endothelial function and circulating endothelial progenitor cells in patients with cardiac syndrome X Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News